Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Michiels, J. J.
Right arrow Articles by van Vliet, H. H.D.M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Michiels, J. J.
Right arrow Articles by van Vliet, H. H.D.M.
NEUROLOGY 1993;43:1107
© 1993 American Academy of Neurology

Transient neurologic and ocular manifestations in primary thrombocythemia

Jan J. Michiels, MD, PhD, Peter J. Koudstaal, MD, PhD, Andries H. Mulder, MD, PhD and Huub H.D.M. van Vliet, PhD

Departments of Hematology, Neurology, and Pathology, University Hospital Dijkzigt, Erasmus University, Rotterdam, The Netherlands.

We report the presenting neurologic and visual symptoms in 17 patients with primary thrombocythemia. Poorly localizing symptoms occurred in 14 patients: transient unsteadiness in 13, dysarthria in eight, and scintillating scotomata in four. Nine patients had focal symptoms: transient monocular blindness in two patients, transient mono- or hemiparesis in six, and both of these in one patient. The attacks all had a sudden onset, occurred sequentially rather than simultaneously, lasted for a few seconds to several minutes, and were usually associated with a dull or pulsatile headache. A causal platelet-mediated arterial thrombosis was evident in 15 patients. There were no recurrences of thrombotic or ischemic events during long-term treatment of 12 patients with aspirin and during cytostatic reduction of platelet count to normal in seven patients. We conclude that low-dose aspirin and reduction of platelet count to normal are effective, but coumarin is ineffective, in the treatment and prevention of arterial thrombosis in thrombocythemia.

Address correspondence and reprint requests to Dr. Jan J. Michiels, Department of Hematology, University Hospital Dijkzigt, 40 Dr Molewaterplein, 3015 GD Rotterdam, The Netherlands.

Received July 7,1992. Accepted for publication in final form October 2, 1992.




This article has been cited by other articles:


Home page
StrokeHome page
L. I. Kornblihtt, S. Cocorullo, C. Miranda, P. Lylyk, P. G. Heller, and F. C. Molinas
Moyamoya Syndrome in an Adolescent With Essential Thrombocythemia: Successful Intracranial Carotid Stent Placement
Stroke, August 1, 2005; 36(8): e71 - e73.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
J. L. Spivak
Polycythemia vera: myths, mechanisms, and management
Blood, December 15, 2002; 100(13): 4272 - 4290.
[Full Text] [PDF]


Home page
CLIN APPL THROMB HEMOSTHome page
M. S. Laguna, L. I. Kornblihtt, R. F. Marta, J. J. Michiels, and F. C. Molinas
State-of-the-Art Review : Effectiveness of Anagrelide in the Treatment of Symptomatic Patients with Essential Thrombocythemia
Clinical and Applied Thrombosis/Hemostasis, July 1, 2000; 6(3): 157 - 161.
[Abstract] [PDF]


Home page
CLIN APPL THROMB HEMOSTHome page
J. J. Michiels
Aspirin and Platelet-Lowering Agents for the Prevention of Vascular Complications in Essential Thrombocythemia
Clinical and Applied Thrombosis/Hemostasis, October 1, 1999; 5(4): 247 - 251.
[Abstract] [PDF]


Home page
CLIN APPL THROMB HEMOSTHome page
J. J. Michiels
Acquired von Willebrand Disease Due to Increasing Platelet Count Can Readily Explain the Paradox of Thrombosis and Bleeding in Thrombocythemia
Clinical and Applied Thrombosis/Hemostasis, July 1, 1999; 5(3): 147 - 151.
[Abstract] [PDF]


Home page
CLIN APPL THROMB HEMOSTHome page
J. J. Michiels
Normal Life Expectancy and Thrombosis-Free Survival in Aspirin Treated Essential Thrombocythemia
Clinical and Applied Thrombosis/Hemostasis, January 1, 1999; 5(1): 30 - 36.
[Abstract] [PDF]


Home page
NEJMHome page
P. van Genderen, J. J. Michiels, T. Ring, R. H. Feiner, S. Cortelazzo, G. Finazzi, and T. Barbui
Hydroxyurea in Essential Thrombocytosis
N. Engl. J. Med., September 21, 1995; 333(12): 802 - 803.
[Full Text]


Home page
ANGIOLOGYHome page
P. J. J. van Genderen and J. J. Michiels
Arterial Thrombophilia in Primary Thrombocythemia: A Case Report
Angiology, June 1, 1994; 45(6): 485 - 488.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1993 by AAN Enterprises, Inc.